Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.

Chest - 1 Mar 2002

Braunstein Joel B, Kershner Dawn Warner, Bray Paul, Gerstenblith Gary, Schulman Steven P, Post Wendy S, Blumenthal Roger S

Abstract excerpt

Genetic variants of key hemostatic mediators increasingly have been proposed as risk factors for atherothrombosis. The Hormone and Estrogen/Progestin Replacement Study group recently reported that the initiation of estrogen replacement in postmenopausal women with known coronary heart disease is associated with an early increase in cardiovascular events. A putative genetic susceptibility factor has been proposed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Factors
Share to Estrogen Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VII

Share to Fibrinogen

Share to Hemostasis

Share to Plasminogen Activator Inhibitor 1

Share to Postmenopause

Share to Prothrombin

Source

Identifiers

PMID: 11888977
DOI: 10.1378/chest.121.3.906

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.PMID 11888977Read ↗

Estrogen therapy and thrombotic risk.Semantic proximity Read ↗

Genetics of arterial prothrombotic risk states.Semantic proximity Read ↗

Genetic risk factors for arterial thrombosis and inflammation.Semantic proximity Read ↗

Invited review: Pharmacogenetics of estrogen replacement therapy.Semantic proximity Read ↗

Genetics of atherothrombosis and thrombophilia.Semantic proximity Read ↗

Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: implications for hormone replacement therapy.Semantic proximity Read ↗

Dissecting the genetic determinants of hemostasis and thrombosis.Semantic proximity Read ↗

Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.Semantic proximity Read ↗

Haemostatic genetic risk factors in arterial thrombosis.Semantic proximity Read ↗

Interaction of estrogen replacement therapy with the thrombophilic 20210 G/A prothrombin gene mutation for atherothrombotic vascular disease: a cross-sectional study of 275 hyperlipidemic women.Semantic proximity Read ↗

Update on genetic risk factors for thrombosis and atherosclerotic vascular disease.Semantic proximity Read ↗

Genetic Determinants of Arterial ThrombosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.